Verapamil in cardiology.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001001:Anura; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced / Q000188:drug therapy; D002118:Calcium / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002415:Cats; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014665:Vasodilator Agents / Q000494:pharmacology; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D014665:Vasodilator Agents; D014700:Verapamil; D007545:Isoproterenol; D002118:Calcium